MedTrace Logo

Evaluation of Autonomic System Before and After Anticholinergic Treatment in Women With Overactive Bladder

NCT01409512 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2011-08-04

No results posted yet for this study

Summary

The aim of the study is to evaluate changes in autonomic nervous system following treatment with anticholinergic medication for OAB symptoms.

Heart variability as a measure of the functioning of the autonomic nervous system will be recorded before and three months following treatment with solifenacin succinate 10 mg daily.

Conditions

Interventions

PROCEDURE

ECG recording

At baseline and following 3 months on anticholinergic medications patients, ECG recording will be conducted.

Sponsors & Collaborators

  • Rambam Health Care Campus

    lead OTHER

Principal Investigators

  • Lior Lowensrtein, MD · Rambam Health Care Campus

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01409512 on ClinicalTrials.gov